PMD23- IS MARKOV CHAIN/DECISION TREE APPROACH BETTER THAN COST FUNCTION APPROACH IN MODELING THE PHARMACEUTICAL COSTS FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER? AN EMPIRICAL STUDY BASED ON A LARGE CLAIM DATABASE
Abstract
Authors
P Sun R Swindle